TNKASE (tenecteplase) - Roche, Boehringer Ingelheim
Activase (alteplase) - Roche, Boehringer Ingelheim, Kyowa Kirin, Tanabe Pharma
Tenecteplase in acute ischemic stroke: an updated meta-analysis. (PubMed, Front Neurol) - Oct 1, 2026 - "Tenecteplase (TNK) has emerged as a promising alternative to alteplase (tPA) for intravenous thrombolysis in acute ischemic stroke (AIS). Further high-quality RCTs are warranted to confirm these findings. CRD420251030320." 
Clinical • Journal • Retrospective data • Review • Cardiovascular • Ischemic stroke
http://www.ncbi.nlm.nih.gov/pubmed/42812199
 
Ahmed Salah Morad; Bayan Mohammed Khair Al Zoabi; Bushra Wadi Bin Saddiq; Fatimah Ibrahim Almuhaysin; Husna Irfan Thalib; Hussain Almohammed; Tanveer Nidal Khan; Wejdan Ahmed Aldawsari; Zainab Alabdi
 
Oct 1, 2026
 
Prev Next